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The  transfer  of  thoracic duct  lymphocytes from normal syngeneic donors 
fails  to  initiate  a  hemolysin response  in  rats  tolerant  of sheep  erythrocytes. 
Although some hemolysin is formed in response to the challenge of sublethally 
irradiated  tolerant recipients  of thoracic duct lymphocytes from normal rats, 
this  response  is  much weaker  than  that  observed  in  irradiated  normal  rats 
similarly resuscitated with lymphocytes. It appears likely that such hemolysin 
formation in irradiated tolerant rats that have been resuscitated with lympho- 
cytes  is  attributable  to  the  transferred  cells  (1).  The  failure  of  transferred 
lymphocytes to  abrogate  tolerance  in  unirradiated  tolerant  rats  cannot  be 
dismissed as the inability of the normal cells  to colonize the lymphoid tissues 
of  the  host.  When  "normal"  lymphocytes  are  injected  intravenously  into 
tolerant rats, many of these cells localize in the host's spleen; they retain their 
capacity to differentiate for antibody formation provided they do not remain 
in the tolerant host for more than 3 days (2). After this period, cells with anti- 
body-forming potentiality can no longer be recovered from the tolerant host's 
spleen.  Despite  this  initial  occurrence  of  antibody-forming  cell  precursors, 
differentiated  plaque-forming  cells  cannot  be  detected  in  the  spleen  of  the 
tolerant host at any time after the receipt of normal syngeneic lymphocytes. 
In contrast to these previous experiments,  the present investigation is con- 
cerned with  the  transfer  of  allogeneic  lymphocytes to  tolerant  rats.  In  this 
situation,  a  strong hemolysin response may be observed in the tolerant host. 
This  paper  describes  some  of  the  features  of  this  abrogation of erythrocyte 
tolerance following the transfer of allogeneic lymphocytes. 
Malerials and Methods 
Rats.--The rats used in these experiments came from two inbred colonies of Lewis and DA 
strains.  (Lewis)< DA)F1 hybrid rats were bred from members of these two strains. The 
breeding nuclei of both strains were obtained from the Walter and Eliza Hall Institute, Mel- 
bourne, Australia; the colonies were based on rats provided by Dr. W. K. Silvers. 
Induction and Maintenance of Immunological Tolerance of Sheep Erythrocytes.--Performed 
as described in a previous paper (1). 
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Induction and Tolerance of  (Lewis X  DA)F1  Hybrid Tissues in Lewis Rats.--Newborn 
rats of the Lewis strain received approximately 10  s thoracic duct lymphocytes from a  (Lewis 
X  DA)F1 hybrid donor by the intravenous route. The lymphocyte donor was reserved and 
used as a source of skin for grafting of the injected Lewis rats at 6 wk of age. If a skin graft 
was intact 30 days after grafting, its recipient was classified as "tolerant." 
Skin Grafting.--6 wk old Lewis rats which had received (Lewis X  DA)F1 hybrid lympho- 
cytes at birth were grafted with skin from the same donor. Full-thickness skin grafts  were 
transferred, under sterile conditions, to the right flank of the host. 
Collection of Cells.--Lymphocytes were collected from unanesthetized rats using Gowans' 
(3) modification of the method of thoracic duct cannulation of Bollman, Cain, and Grindlay 
(4). Thymus cells were prepared by gently teasing this organ apart in ice-cold Hanks' saline 
with fine forceps. 
Hemolytic Plaque-Forming Cell Assays.--Performed  using  Cunningham  and  Szenberg's 
(5) modification of the technique of Jerne, Nordin, and Henry (6). 
Isoantisera Incubation of Cells.--Rat  isoantisera were prepared by injecting members of 
one strain of rat with lymphoid cells from the other strain. Each prospective antiserum donor 
received an initial intraperitoneal injection of approximately l0  s thoracic duct lymphocytes 
from a rat of the other strain, suspended in complete Freund's adjuvant. Two or three sub- 
sequent intraperitoneaI injections of thoracic duct lymphocytes or spleen ceils were given at 
intervals ranging from 1 wk to  1 month. Antiserum was prepared from blood taken 7 days 
after the last injection. 
When spleen cells were to he incubated with antisera prior to testing for plaque-forming 
cells the following procedure was followed, each cell suspension being incubated with both 
anti-DA and anti-Lewis sera. 2  X  107 cells suspended in 0.2 ml of medium 199 were mixed 
with 0.2 ml of a 1:3 dilution of the specific antiserum in medium 199. 0.2 ml of a 50% mixture 
of freshly reconstituted lyophilized guinea pig serum  (Commonwealth Serum Laboratories, 
Melbourne, Australia) was added as a  source of complement. After incubation at 37°C  for 
25  min, the ceils were counted, washed in ice-cold Hanks' saline to remove antiserum,  re- 
suspended at a concentration of 10  7 cells/ml, and tested for plaque-forming cell content. As 
previously reported (7 and 8), there was a variable degree of nonspecific loss of plaque-forming 
cells during incubation. No allowance for this loss has been incorporated in the presentation 
of the results of incubation with isoantisera. Thus, the numbers given for survival of plaque- 
forming cells/10  ~ spleen cells,  after incubation of each specimen in Lewis and DA sera,  are 
the results actually obtained. 
Hemolysin Titrations.--Performed on sera as described in a previous paper (1). 
RESULTS 
Rats  tolerant of sheep erythrocytes were injected with allogeneic lympho- 
cytes together with sheep erythrocytes. The recipients' spleens were examined 
subsequently for the presence of plaque-forming cells. 
The Effect  of  Transferring  Lymphocytes from Normal  Rats  of Lewis Strain  to 
Erythrocyte-Tolerant  (Lewis X  DA)F1 Hybrid Rats 
(Lewis)<  DA)F1 hybrid rats,  which were tolerant of sheep erythrocytes as a 
result of repeated  injections of this antigen since birth,  received thoracic duct 
lymphocytes from normal Lewis rats and were simultaneously challenged with 
l0  s sheep erythrocytes. The spleens  of  the recipients were  examined for hemo- 
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body-forming cells were regularly detected (Table I). There did not appear to 
be  any correlation between  the  numbers  of lymphocytes transferred  and  the 
yield  of  plaque-forming  cells  over  the  range  of  lymphocyte  dosage  tested 
(3 X  108-11.5  X  10s). While larger numbers of lymphocytes were used initially, 
as few as 108  cells were  subsequently found  to be  effective  (Table V). When 
the origin of the plaque-forming cells was tested by means of specific isoanti- 
sera, the majority of these cells were found to be of host origin. 
TABLE I 
The Transfer of Lymphocytes  from Lewis Rats to  (Lewis X  DA) F1 Hybrid Rats Tolerant of 
Sheep Erythrocytes 
No. of lymphocytes  Interval before  PFC 
transferred  PFC  (per spleen) 
(X  l0 s)  determination 
Origin of PFC as determined by incubation 
with isoantisera 
(PFC/t0 6 spleen cells) 
Preincubation 
Incubated  Incubated 
with anti-  with anti- 
DA serum  Lewis serum 
hr 
3  89  170,000 
6.2  96  107,000 
7.2  94  340,000 
8  90  720,000 
9.2  94  158,000 
11.5  96  290,000 
2.5  92  166,000 
2.5  92  1,625,000 
4  92  802,000 
4  92  434,000 
130  1  4 
1,260  17  180 
590  104  102 
350  13  43 
Thoracic  duct lymphocytes were administered intravenously, together with  l0 s  sheep 
erythrocytes, to each tolerant rat. Technique  of incubation of spleen cells with isoanfisera is 
described in Materials and Methods. Numbers of plaque-forming cells (PFC)/106  spleen cells 
surviving incubation with isoantisera are expressed as determined without any modification 
for nonspecific loss. 
Plaque-forming cells of host (hybrid) type would be expected to be susceptible to both iso- 
antisera used. Any plaque-forming cells derived from the donor (Lewis) should be insusceptible 
to anti-DA serum. Thus, while incubation with anti-Lewis serum cannot indicate origin of 
plaque-forming  cells, incubation with anti-DA serum will only decrease plaque-forming  cells 
of host origin. 
The  Effect  of  Transferring  Lymphocytes from  Normal  Rats  of  DA  Strain  to 
Erythrocyte- Tolerant Lewis Rats 
The lymphocytes from parental strain rats, which were transferred to hybrid 
rats  in  the  preceding  experiments,  were  capable of  initiating  a  graft-versus- 
host reaction directed against the host,  but were  themselves insusceptible to 
homograft rejection by the host. The effect of transferring allogeneic lympho- 
cytes which would themselves be subject to homograft rejection by the erythro- PETER  J. MCCULLAGI-I  919 
cyte-tolerant  host  has  been  tested  (Table  II).  Although  prolonged  survival 
of  the  transferred  cells  in  this  situation  is  not  possible,  abrogation  of  host 
tolerance  of sheep erythrocytes was  again  observed. A  similar  result  was ob- 
tained  when  the  direction  of  lymphocyte  transfer  was  from Lewis  to  DA, 
i.e.,  the  opposite  direction  to  the  experiments  summarized  in  Table  II.  The 
majority of the  plaque-forming cells  in these  experiments  were again  of host 
origin. 
TABLE II 
The Transfer of Lymphocytes from DA Rats to Lewis Rats Tolerant of Sheep Erythrocytes 
No. of lympho-  Interval before 
cytes trans-  PFC deter-  PFC (per spleen) 
ferred (X  10a)  ruination 
Origin of PFC as determined by incubation 
with isoantisera  (PFC/lO s spleen cells) 
Preincubation  Incubated  with  Incubated with 
anti-DA serum  anti-Lewisserum 
h~ 
3.6  92  83,000 
4  108  8,000 
6  89  310,000 
2.5  93  15,700  32  28  5 
2.5  93  24,800  27  25  3 
3.6  92  158,000  110  88  11 
3.6  92  200,000  200  110  19 
5.4  92  162,000  202  150  8 
6.6  76  380,000  328  214  38 
7  86  99,000  166  112  24 
The experimental system, apart from the types of lymphocyte donor and host, was simi- 
lar to that in Table I. Plaque-forming cells (PFC) of donor type should be susceptible to anti- 
DA serum only, whereas cells of host type should be susceptible only to anti-Lewis serum. 
The Effect of Transferring  Lymphocytes from Normal (Lewis X  DA )F1 Hybrid 
Rats to Erythrocyte-Tolerant  Rats of the DA Strain 
Lymphocytes derived from a  hybrid rat  are incapable  of initiating  a  graft- 
versus-host  reaction  in a  host of the parental  strain.  Furthermore,  the  trans- 
ferred  cells  will  be  themselves  subject  to  homograft  rejection  by  the  host. 
Nevertheless,  such  lymphocytes  are  capable  of  evoking  the  abrogation  of 
erythrocyte tolerance in parental strain recipients  (Table III). 
The Effect of Transferring Thymus Cells from Normal DA Strain Rats 
to Erythrocyte-Tolerant  Rats of Lewis Strain 
The  capacity of thymus-cell  suspensions  prepared  from DA strain  rats  to 
evoke  production  of  plaque-forming  cells  in  erythrocyte-tolerant  Lewis  rats 
has been tested. Although abrogation of tolerance was effected, the number of 
plaque-forming  cells  produced  tended  to  be  less  than  the  number  produced 920  ALLOGENEIC ABROGATION  OF TOLERANCE 
following the injection of allogeneic thoracic duct lymphocytes. This occurred 
even though the  numbers of  thymocytes transferred were larger  (Table IV). 
TABLE III 
The Transfer of Lymphocytes  from (Lewis X  DA) F1 Hybrid Rats to DA Rats Tolerant of Sheep 
Erythrocytes 
No. of tymphocytes  Interval before PFC*  PFC  (per spleen) 
transferred  O< 10  8)  determination 
hr 
5.7  90  12,000 
6  95  450,000 
6  110  240,000 
The experimental system, apart from the types of lymphocyte donor and recipient, re 
sembled that of Table I. 
* PFC, plaque-forming cells. 
TABLE  IV 
The Transfer of Allogeneic Thymus or Bone Marrow Cells to Rats Tolerant of Sheep Erythrocytes 
Interval 
Tolerant recipient  No. of cells transferred (X 10s)  before PFC  PFC  (per spleen)  deter- 
mination 
hr 
Lewis  10 DA thymus  88  nil 
10  90  3,000 
8.5  92  21,000 
8.5  94  125,000 
10  97  14,000 
(Lewis X DA) F1 hybrid  2 Lewis bone marrow  89  nil 
2  "  "  92  1,300 
2  "  "  96  4,100 
2  "  "  99  1,500 
The thymic or bone marrow ceils were administered intravenously together with l0  s sheep 
erythrocytes to each tolerant rat. 
The Effect of Transferring  Bone Marrow Cells from Normal Lewis Strain  Rats 
to Erythrocyte-Tolerant  (Lewis  X  DA )F1 Hybrid Rats 
Allogeneic bone marrow cells were of very low efficiency with regard to the 
abrogation of tolerance (Table IV). 
The Effect of Transferring Lymphocytes from Lewis Rats  Tolerant of 
(Lewis >( DA)F1 Hybrid Tissues to Erythrocyte-Tolerant Hybrid Rats 
To  determine  whether  genetic  disparity  between  lymphocyte  donor  and 
tolerant host is sufficient to ensure the abrogation of tolerance of sheep erythro- 
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lations  of  unrelated  cells  is  required,  further  experiments  were  performed. 
The procedure was identical with that described earlier except for the substitu- 
tion as the lymphocyte donor of a  Lewis rat tolerant of hybrid tissues for a 
normal rat. At the time of thoracic duct cannulation,  the lymphocyte donor 
had been bearing  a  graft of hybrid strain  skin for 6  wk.  Although  the  skin 
graft was in good condition at this time, its subsequent contraction indicated 
that  tolerance  was  not  complete.  Each  of  the  erythrocyte-tolerant  hybrids 
received from l0  s to 2 )<  10  s Lewis strain lymphocytes. Control experiments in 
TABLE V 
The Effect of Transferring Thoracic Duct Lymphocytes or Spleen Cells  from Lewis Rats Tolerant 
of (Lewis X  DA) F1 Hybrid Tissues to (Lewis X  DA) F1 Hybrid Rats Tolerant of 
Sheep Erythrocytes 
Status of cell donor (with  respect  to hybrid tissues)  No. of cells transferred (X IO  s)  Interval before PFC  determination  PFC  (per spleen) 
hr 
normal  1 TDL*  91  85,000 
normal  1.5 TDL  91  330,000 
normal  2 TDL  91  21,000 
tolerant  1.5 TDL  89  nil 
tolerant  2 TDL  92  2,400 
tolerant  1 TDL  94  900 
tolerant  2 TDL  100  1,700 
tolerant  1.5 TDL  100  200 
tolerant  1.5 TDL  109  nil 
normal  3.6 spleen cells  90  124,000 
normal  3.6 spleen cells  97  653,000 
tolerant  3.6 spleen cells  90  3,700 
tolerant  3.6 spleen cells  97  1,200 
* TDL, thoracic duct lymphocytes. 
Each tolerant recipient received  Lewis strain cells plus 108 sheep erythrocytes intravenously. 
which similar numbers of lymphocytes from untreated Lewis rats were trans- 
ferred to erythrocyte-tolerant hybrid rats had indicated that abrogation could 
be  effectively achieved  with  this  cell  dosage  (Table  V).  In  contrast,  when 
lymphocytes  from  a  donor  tolerant  of  hybrid  tissues  were  transferred  to 
erythrocyte-tolerant hybrid  rats,  very few plaque-forming  cells  appeared  in 
the spleens of the recipients (Table V). Spleen cells from a Lewis rat tolerant of 
(Lewis  X  DA)F1 hybrid tissues evoked very few plaque-forming cells in  the 
spleens  of  erythrocyte-tolerant hybrid  recipients  in  comparison  with  spleen 
cells from normal Lewis rats (Table V). 
The Effect of Transferring Lymphocytes from Erythrocyte-Tolerant Lewis Rats to 
Erythrocyte-Tolerant  (Lewis >( DA)F1 Hybrid Rats 
This group of experiments was similar to those described earlier except for 
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Lewis rats.  Thus,  both  lymphocyte donors  and lymphocyte recipients  were 
tolerant of sheep erythrocytes. If abrogation of tolerance were to require on 
the part of the transferred lymphocytes some factor specifically required for a 
hemolysin response that was absent from the cells  of the tolerant rat,  then 
the injection of cells from an allogeneic but erythrocyte-tolerant donor should 
not produce abrogation. However, abrogation of tolerance was found to be at 
least as marked as in similar tolerant hybrid rats receiving lymphocytes from 
normal (nontolerant) Lewis rats (Table VI). 
TABLE  VI 
The Effect of Transferring Lymphocfles from Erythrocyte-Tolerant Lewis Rats to Erythrocyte- 
Tolerant (DA  X  Lewis) F1 Hybrid Rats 
No. of lymphocytes transferred  Interval before PFC  PFC (per spleen) 
(X 10s)  determination 
hr 
1.7  93  440,0O0 
2  93  360,000 
3.7  94  100,000 
6.3  92  87,000 
13  96  1,380,000 
Thoracic duct lymphocytes plus 10 8 sheep erythrocytes were administered intravenously to 
each tolerant rat. 
DISCUSSION 
Thoracic duct lymphocytes from normal rats  are  incapable  of abrogating 
tolerance of sheep erythrocytes in syngeneic recipients. The possibility that 
syngeneic lymphocytes transferred to a  tolerant host are subject to a specific 
suppression  of the relevant immunological reactivity in the  transferred cells 
has  been  suggested  (2).  When  this  failure  of  transferred  syngeneic cells  to 
break  tolerance  is  considered,  abrogation  of  tolerance  by  allogeneic cells  is 
surprising. In an attempt to delineate the cellular basis of this abrogation, the 
origin of the plaque-forming cells was analyzed by means of isoantisera. This 
technique clearly established that the majority of the plaque-forming cells are 
derived from cells of the tolerant host. Nonspecific loss of plaque-forming cells 
during  incubation  with  antisera  impairs  the  quantitative  accuracy  of  the 
determination.  However,  the  incrimination that  plaque-forming cells  are  of 
host origin regardless of the strain of host (Table I  and II) excludes the possi- 
bility of a nonspecific bias towards survival of cells of one particular genotype 
during incubation. 
The demonstration that the plaque-forming cells appearing after the trans- 
fer of allogeneic  lymphocytes to tolerant rats are of host origin suggests that 
the mechanism of abrogation observed here differs fundamentally from that 
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rats. In this latter situation, the hemolysin response appears to be attributable 
to lymphocytes transferred from the normal donor (1). 
Consideration  of the  variety of strain  combinations  of lymphocyte donor 
and tolerant host which result in abrogation of tolerance gives some indication 
of the nature of this process. The observation that hybrid strain lymphocytes 
abrogate tolerance in DA rats and DA strain lymphocytes abrogate tolerance 
in Lewis rats implies that prolonged survival of the transferred cells is not a 
prerequisite for abrogation. Thus, in both of the preceding situations, rejection 
of the transferred cells by a  homograft reaction would be expected to inter- 
vene, probably before the time at which abrogation of tolerance becomes ap- 
parent.  Furthermore,  it will be  seen  that  neither  a  graft-versus-host  attack 
mounted by the transferred lymphocytes, nor a  homograft reaction directed 
against these cells by the host is a  common feature of all of the donor-host 
combinations in which abrogation occurs. The only feature that is common to 
all of the effective combinations is that there exists the capacity for an inter- 
action between the transferred lymphocytes and tolerant host. Either a graft- 
versus-host reaction or a homograft reaction will suffice. 
The  observations  discussed  above  indicate  that  a  difference in  genotype 
between lymphocyte donor and tolerant host is required. They do not, however, 
distinguish between the requirement for a genetic disparity alone and the need 
for  an  immunological  interaction  to  occur  between  lymphocytes  and  host 
cells.  In most donor-host combinations, both of these requirements would be 
met simultaneously and, hence, it would not be possible to determine whether 
both were necessary. A distinction can be drawn between the requirement for 
genetic  disparity  alone  or  for  the  additional  occurrence  of  immunological 
interaction by transferring allogeneic lymphocytes from a  donor tolerant of 
the tissues of the erythrocyte-tolerant host. It is apparent that, when lympho- 
cytes from a  parental-strain rat tolerant of hybrid tissues are transferred to 
a hybrid rat, there will be a genetic difference between donor and host but no 
immunological reaction will occur. When this experiment was undertaken, the 
parental strain lymphocyte donor appeared fully tolerant of hybrid tissues at 
the  time  of thoracic duct cannulation,  but  subsequent  slow cicatrization of 
its skin graft indicated that tolerance was incomplete. In view of this incom- 
pletion, the very marked discrepancy in abrogating capacity when transplanta- 
tion-tolerant lymphocytes are compared with normal lymphocytes is striking. 
Cells from a homograft-tolerant donor have little capacity to evoke abrogation. 
It can be confidently inferred from this observation that the genetic disparity 
between the  transferred lymphocytes and  their tolerant host is  not of itself 
sufficient for abrogation. An immunological interaction between graft and host 
is also mandatory. 
The reduced ability of allogeneic thymus cells to abrogate tolerance is  in 
accord with the generally reduced immunological capacity of these cells when 
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in  achieving  abrogation  correlates  with  the  immunological  capabilities  of 
this cell population. 
Investigation is being directed to the elucidation of the mechanism of abroga- 
tion  of  tolerance  following  immunological  interaction  between  transferred 
lymphocytes and  host  cells.  In  one experiment, reported in  this  paper,  the 
efficacy of lymphocytes transferred from erythrocyte-tolerant, allogeneic donors 
for  abrogation  of erythrocyte tolerance in  the  host  was  examined.  This ex- 
periment was  intended to test the possibility that,  as a  result of, and in the 
course of the immunological interaction between transfused lymphocytes and 
host  cells,  a  factor  specifically required  for  hemolysin  formation  could  be 
transferred to the host cells.  If the  absence of such a  factor was  responsible 
for the specific incompetence of tolerant cells,  it is evident that lymphocytes 
transferred from erythrocyte-tolerant donors would  be  unable  to  supply  it; 
lymphocytes from such a source would be incapable of abrogating tolerance. 
That  lymphocytes  from  erythrocyte-tolerant  donors  effectively  abrogate 
tolerance in allogeneic recipients makes such a hypothesis untenable. It seems 
most unlikely that  transferred allogeneic lymphocytes abrogate tolerance by 
providing a factor specifically required for a hemolysin response but which is 
lacking from the cells of the tolerant rat. 
Although the mechanism of abrogation of tolerance with allogeneic lympho- 
cytes remains unclear,  some inferences can be drawn  concerning the cellular 
basis of tolerance of erythrocytes. When a population of lymphocytes manifests 
immunological tolerance, this is most commonly considered to be a consequence 
of the death or irreversible inactivation of all of its cells capable of responding 
to the tolerated antigen. If this explanation is correct, the abrogation of tol- 
erance will require the reappearance of cells with the relevant reactivity. Such 
cells may have been present previously in undetectably small numbers or may 
have arisen spontaneously by mutation. An alternative explanation has been 
proposed for sheep erythrocyte tolerance of rats (2). This explanation, namely 
that a population of cells is tolerant because it contains tolerant cells in which 
a particular reactivity has been repressed, is supported by the current experi- 
ments. If tolerance reflects the presence of tolerant cells, its abrogation is most 
likely  to  entail  the  reversal  of  this  condition  in  individual  cells,  i.e.,  their 
"derepression." Under these circumstances, the sudden appearance of a  large 
population of immune cells might be predicted as a result of derepression of a 
preexisting population of tolerant cells.  The current observations would seem 
to be more satisfactorily accommodated in a scheme of this type than in one 
which requires a very small or newly generated population to have undergone 
rapid multiplication. As an example of the rapid appearance of a large number 
of plaque-forming cells in  a  rat previously tolerant,  380,000  such  cells were 
present in the spleen of one Lewis rat 76 hr after stimulation (Table II). Any 
preexisting population  of  reactive cells,  of which  these  plaque-forming cells 
are  postulated  to be  the  progeny, would  be required  to be  extremely small PETER  J.  McCULLAGH  925 
when  one  considers  the  consistent  inability  to  detect  any  plaque-forming 
cells following  antigenic  challenge  of  tolerant  rats  (2).  It  is  not  possible  to 
unequivocally exclude an extremely rapid multiplication of reactive host cells 
present in undetectably small numbers in the present experiments. However, 
it  seems to be a  most unlikely explanation.  The  conversion of tolerant  cells 
to  immune  cells  could  explain  the  sporadic  breakage  of  tolerance  reported 
when a tolerant population of lymphocytes is maintained in vitro (9). 
SIJ"MM.ARY 
Whereas the transfer of lymphocytes from normal syngeneic donors fails to 
abrogate tolerance of sheep erythrocytes in rats, lymphocytes from allogeneic 
donors are effective. When tolerance is abrogated in this situation,  the hemol- 
ysin-forming cells are predominantly of host origin. Immunological interaction 
between transfused lymphocytes and host cells is a prerequisite for the abroga- 
tion of tolerance. From the time required for abrogation to occur after transfer 
of the  allogeneic cells,  it is suggested that tolerance of sheep erythrocytes in 
rats represents the  repression of a  specific reactivity in  cells rather  than  the 
elimination or irreversible inactivation of reactive cells. This explanation im- 
plies the existence of specifically tolerant cells. 
I Msh to acknowledge the excellent technical assistance of Mrs. E. Johnson. 
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